EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report

Christoph Oster, Benjamin Stolte, Livia Asan, Refik Pul, Stephan Klebe, Martin Köhrmann, Katharina Breuckmann, Christoph Rischpler, Cornelius Deuschl, Sebastian Dolff, Christoph Kleinschnitz, Tim Hagenacker

Journal of Clinical Immunology · 2023

DOI: 10.1007/s10875-023-01526-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Clinical Immunology, 2023. Verfasst von Christoph Oster und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen…. Hauptthemen laut MEDLINE: Common Variable Immunodeficiency, Brain Stem Infarctions, Stroke, Immunologic Deficiency Syndromes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Essen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

We present the case of a 24-year-old male with CNS granulomatosis due to an immunodeficiency syndrome which was identified as deficiency of adenosine deaminase 2 (DADA2) as a cause of brainstem infarction.

Methods

Case report and detailed description of the clinical course of diagnosis and treatment. Case The patient’s medical history consisted of an unknown immunodeficiency syndrome. Based on former findings, common variable immunodeficiency (CVID) was diagnosed. The patient suffered from three consecutive brainstem strokes of unknown etiology within 3 years. An MRI scan detected gadolinium-enhancing, granulomatous-suspect lesions in the interpeduncular cistern, temporal lobe, and tegmentum. Laboratory analysis was compatible with CVID, with leukopenia and immunoglobulin deficiency. Because granulomatous CNS inflammation was suspected, the patient received methylprednisolone immunosuppressive therapy, which led to partially regressive MRI lesions. However, in contrast to imaging, the patient showed a progressive cerebellar syndrome, indicating plasma exchange therapy and immunoglobulin treatment, which led to rapid symptom amelioration. After a relapse and a further stroke, expanded analysis confirmed DADA2 (and not CVID) as the inflammatory cause for recurrent stroke. After starting the therapy with immunoglobulins and adalimumab, no further strokes occurred.

Conclusion

We present the case of a young adult with diagnosis of DADA2 as a cause for recurrent strokes due to vasculitis. This stroke etiology is rare but should be considered as a cause of recurrent stroke of unknown origin in young patients to avoid a disabling disease course by disease-specific treatment options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Common Variable ImmunodeficiencyBrain Stem InfarctionsStrokeImmunologic Deficiency SyndromesAdultAdenosine DeaminaseHereditary Autoinflammatory DiseasesHumansAgammaglobulinemiaIntercellular Signaling Peptides and ProteinsImmunoglobulinsMaleYoung AdultSevere Combined Immunodeficiency

Stichwörter der Autor:innen

AtaxiaCVIDDADA2ImmunoglobulinsImmunosuppressionStroke

Substanzen

Adenosine DeaminaseIntercellular Signaling Peptides and ProteinsImmunoglobulins

Autor:innen und Institutionen

  • Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Nuclear Medicine, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Infectious Diseases, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.
  • Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, Essen, Germany. tim.hagenacker@uk-essen.de.

Förderung

  • Universitätsklinikum Essen

Zitieren

APA

Oster, C., Stolte, B., Asan, L., Pul, R., Klebe, S., Köhrmann, M., Breuckmann, K., Rischpler, C., Deuschl, C., Dolff, S., Kleinschnitz, C., & Hagenacker, T. (2023). Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-023-01526-3

Vancouver

Oster C, Stolte B, Asan L, Pul R, Klebe S, Köhrmann M, et al. Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report. Journal of Clinical Immunology. 2023. doi:10.1007/s10875-023-01526-3

BibTeX
@article{Oster2023,
  author = {Oster, Christoph and Stolte, Benjamin and Asan, Livia and Pul, Refik and Klebe, Stephan and Köhrmann, Martin and Breuckmann, Katharina and Rischpler, Christoph and Deuschl, Cornelius and Dolff, Sebastian and Kleinschnitz, Christoph and Hagenacker, Tim},
  title = {Brainstem Infarction in Immunodeficiency Identified as Adenosine Deaminase 2 Deficiency: Case Report},
  journal = {Journal of Clinical Immunology},
  year = {2023},
  doi = {10.1007/s10875-023-01526-3}
}
Kostenlos starten →